Aytu BioPharma (NASDAQ:AYTU – Get Free Report) issued its quarterly earnings data on Thursday. The company reported ($0.82) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.45) by ($0.37), Zacks reports. The company had revenue of $17.98 million for the quarter. Aytu BioPharma had a negative return on equity of 31.31% and a negative net margin of 14.60%.
Aytu BioPharma Trading Down 17.2 %
Shares of NASDAQ:AYTU traded down $0.49 on Friday, hitting $2.36. The company had a trading volume of 237,675 shares, compared to its average volume of 20,737. The company has a market cap of $14.09 million, a PE ratio of -0.90 and a beta of -1.43. The business has a 50 day moving average of $2.52 and a 200 day moving average of $2.82. Aytu BioPharma has a 52-week low of $1.87 and a 52-week high of $3.50.
About Aytu BioPharma
Further Reading
- Five stocks we like better than Aytu BioPharma
- What Are Trending Stocks? Trending Stocks Explained
- CarMax’s Impressive Rally: What Investors Should Watch Next
- Low PE Growth Stocks: Unlocking Investment Opportunities
- MarketBeat Week in Review – 9/23 – 9/27
- Where Do I Find 52-Week Highs and Lows?
- Wake Up to This Biotech Stock That Still Has Big Potential Upside
Receive News & Ratings for Aytu BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aytu BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.